PPJ Healthcare Enterprises, Inc.

The company's financials show resilient growth, with revenue advancing from $231909.00 in Q3 2023 to $193762.00 in Q2 2024. Gross profit remained healthy with margins at 24% in Q2 2024 compared to 41% in Q3 2023. Operating income hit $35429.00 last quarter, sustaining a consistent 18% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $35429.00. Net income rose to $35429.00, while earnings per share reached $0.00. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.